Tafamidis Should Be Accessible for All Patients With Transthyretin Amyloid Cardiomyopathy

被引：0
|
作者：
Psotka, Mitchell A. [1 ]
机构：
[1] Inova Heart & Vasc Inst, 3300 Gallows Rd, Falls Church, VA 22042 USA
来源：
JACC-HEART FAILURE | 2021年 / 9卷 / 02期
关键词：
access to care; cost; hereditary; tafamidis; TTR amyloidosis;
D O I：
10.1016/j.jchf.2020.12.001
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：124 / 126
页数：3
相关论文
共 50 条
  • [1] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, Rene
    Duca, Franz
    Binder, Christina
    Capelle, Christophe
    Eslam, Roza Badr
    Aschauer, Stefan
    Mascherbauer, Julia
    Hengstenberg, Christian
    Bonderman, Diana
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : S452 - S452
  • [2] Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
    Rettl, R. Rene
    Mann, C.
    Duca, F.
    Dachs, T-M
    Binder, C.
    Kronberger, C.
    Dusik, F.
    Ligios, L. Camuz
    Schrutka, L.
    Dalos, D.
    Charwat-Resl, S.
    Kastner, J.
    Eslam, R. Badr
    Bonderman, D.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 252 - 253
  • [3] Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
    Maurer, Mathew S.
    Schwartz, Jeffrey H.
    Gundapaneni, Balarama
    Elliott, Perry M.
    Merlini, Giampaolo
    Waddington-Cruz, Marcia
    Kristen, Arnt V.
    Grogan, Martha
    Witteles, Ronald
    Damy, Thibaud
    Drachman, Brian M.
    Shah, Sanjiv J.
    Hanna, Mazen
    Judge, Daniel P.
    Barsdorf, Alexandra I.
    Huber, Peter
    Patterson, Terrell A.
    Riley, Steven
    Schumacher, Jennifer
    Stewart, Michelle
    Sultan, Marla B.
    Rapezzi, Claudio
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11): : 1007 - 1016
  • [4] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, Rene
    Duca, Franz
    Binder, Christina
    Capelle, Christophe
    Aschauer, Stefan
    Mascherbauer, Julia
    Hengstenberg, Christian
    Bonderman, Diana
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 : 315 - 316
  • [5] Tafamidis treatment in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Christopher, M.
    Duca, F.
    Dachs, T.
    Binder, C.
    Kronberger, C.
    Dusik, F.
    Ligios, L. Camuz
    Schrutka, L.
    Dalos, D.
    Charwat-Resl, S.
    Eslam, R. Badr
    Hengstenberg, C.
    Kastner, J.
    Bonderman, D.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2021, 133 (SUPPL 3) : S115 - S115
  • [6] Treatment with Tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Christopher, M.
    Dachs, T.
    Duca, F.
    Binder, C.
    Dusik, F.
    Seirer, B.
    Eslam, R. Badr
    Hengstenberg, C.
    Bonderman, D.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2020, 132 : S306 - S307
  • [7] Effects of tafamidis in patients with transthyretin amyloid cardiomyopathy
    Rettl, R.
    Duca, F.
    Binder, C.
    Capelle, C.
    Aschauer, S.
    Eslam, R. Badr
    Mascherbauer, J.
    Hengstenberg, C.
    Bonderman, D.
    [J]. EUROPEAN HEART JOURNAL, 2019, 40 : 494 - 494
  • [8] Tafamidis for Transthyretin Amyloid Cardiomyopathy
    不详
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 773 - 773
  • [9] A Systematic Review of Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy
    Singh, Bishnu Mohan
    Bohara, Narayan
    Gautam, Kamal
    Basnet, Madan
    Sistu, K. C.
    Binod, K. C.
    Raut, Anuradha
    Phudong, Abisha
    Gautam, Jeevan
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [10] Benefits of tafamidis in patients with advanced transthyretin amyloid cardiomyopathy
    Rapezzi, C.
    Kristen, A., V
    Gundapaneni, B.
    Sultan, M. B.
    Hanna, M.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 2115 - 2115
12345